Data gathered: May 30
AI Stock Analysis - Zura Bio (ZURA)
Analysis generated August 15, 2024. Powered by Chat GPT.
Zura Bio is an innovative biopharmaceutical company dedicated to developing and commercializing novel drug therapies. The company's main focus is on advancing the treatment of rare and severe diseases through cutting-edge biotechnological research and development. With a mission to transform lives through breakthrough therapies, Zura Bio commands attention in the biotech sector for its commitment to innovative healthcare solutions. The company’s pipeline includes several promising candidates currently in various stages of clinical trials, which aim to address unmet medical needs.
Stock Alerts - Zura Bio (ZURA)
 |
Zura Bio | May 16 Price is down by -8.3% in the last 24h. |
|
Zura Bio | May 6 Price is down by -7.6% in the last 24h. |
|
Zura Bio | May 1 Price is down by -7.1% in the last 24h. |
|
Zura Bio | April 30 Price is up by 8.6% in the last 24h. |
Download our app to get future alerts delivered in real-time.
Alternative Data for Zura Bio
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 2,000 | Sign up | Sign up | Sign up |
| Google Trends | 7 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 10 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 907 | Sign up | Sign up | Sign up |
| Twitter Followers | 68 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 40 | Sign up | Sign up | Sign up |
About Zura Bio
Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders.
| Price | $1.03 |
| Target Price | Sign up |
| Volume | 63,810 |
| Market Cap | $62M |
| Year Range | $1 - $4.92 |
| Dividend Yield | 0% |
| PE Ratio | 7.95 |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Zura Bio to Present at the Jefferies Global Healthcare ConferenceMay 26 - Yahoo |
 |
Zura Bio Limited (NASDAQ:ZURA) Receives Consensus Rating of “Buy” from BrokeragesMay 24 - ETF Daily News |
|
HC Wainwright Issues Positive Outlook for Zura Bio EarningsMay 22 - ETF Daily News |
|
What is HC Wainwright’s Forecast for Zura Bio Q1 Earnings?May 21 - ETF Daily News |
|
Zura Bio Launches Global Phase 2 TibuSHIELD Study to Evaluate Tibulizumab in Adults with Hidradenitis SuppurativaMay 19 - Yahoo |
|
Dimensional Fund Advisors LP Takes Position in Zura Bio Limited (NASDAQ:ZURA)May 18 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 0 | 0 | 0 | -17M | -19M | -0.190 |
| Q4 '24 | 2,000 | 1,000 | 1,000 | -14M | -16M | -0.080 |
| Q3 '24 | 0 | 0 | 0 | -21M | -19M | -0.260 |
| Q2 '24 | 0 | 1,000 | -1,000 | -13M | -12M | -0.170 |
| Q1 '24 | 0 | 0 | 0 | -730,000 | -8.4M | -0.020 |
Insider Transactions View All
| Thiara Parvinder filed to sell 1,001,633 shares at $2.7. September 13 '24 |
| Sidhu Someit filed to sell 2,085,418 shares at $3.9. September 6 '24 |
| Ploos Van Amstel Arnout filed to buy 100,000 shares at $6.2. May 23 '24 |
| Nistala Kiran filed to buy 3,195 shares at $3.1. April 24 '24 |
Similar companies
Read more about Zura Bio (ZURA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews & linkedin employees.
What is the Market Cap of Zura Bio?
The Market Cap of Zura Bio is $62M.
What is Zura Bio's PE Ratio?
As of today, Zura Bio's PE (Price to Earnings) ratio is 7.95.
What is the current stock price of Zura Bio?
Currently, the price of one share of Zura Bio stock is $1.03.
How can I analyze the ZURA stock price chart for investment decisions?
The ZURA stock price chart above provides a comprehensive visual representation of Zura Bio's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Zura Bio shares. Our platform offers an up-to-date ZURA stock price chart, along with technical data analysis and alternative data insights.
Does ZURA offer dividends to its shareholders?
As of our latest update, Zura Bio (ZURA) does not offer dividends to its shareholders. Investors interested in Zura Bio should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Zura Bio?
Some of the similar stocks of Zura Bio are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.